Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

1.

Calcitriol treatment is not effective in postmenopausal osteoporosis.

Ott SM, Chesnut CH 3rd.

Ann Intern Med. 1989 Feb 15;110(4):267-74.

PMID:
2913914
[PubMed - indexed for MEDLINE]
2.

Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study.

Gallagher JC, Goldgar D.

Ann Intern Med. 1990 Nov 1;113(9):649-55.

PMID:
2221645
[PubMed - indexed for MEDLINE]
3.

Calcitriol in the treatment of postmenopausal osteoporosis.

Aloia JF, Vaswani A, Yeh JK, Ellis K, Yasumura S, Cohn SH.

Am J Med. 1988 Mar;84(3 Pt 1):401-8.

PMID:
3279769
[PubMed - indexed for MEDLINE]
4.

Stanozolol in postmenopausal osteoporosis: therapeutic efficacy and possible mechanisms of action.

Chesnut CH 3rd, Ivey JL, Gruber HE, Matthews M, Nelp WB, Sisom K, Baylink DJ.

Metabolism. 1983 Jun;32(6):571-80.

PMID:
6341772
[PubMed - indexed for MEDLINE]
5.

Does 1,25(OH)2D3 accelerate spinal bone loss? A controlled therapeutic trial in 70-year-old women.

Jensen GF, Meinecke B, Boesen J, Transbøl I.

Clin Orthop Relat Res. 1985 Jan-Feb;(192):215-21.

PMID:
3881203
[PubMed - indexed for MEDLINE]
6.

Low-dose calcitriol versus calcium in established postmenopausal osteoporosis.

Tilyard M.

Metabolism. 1990 Apr;39(4 Suppl 1):50-2.

PMID:
2325572
[PubMed - indexed for MEDLINE]
7.

Role of calcitriol in the treatment of postmenopausal osteoporosis.

Aloia JF.

Metabolism. 1990 Apr;39(4 Suppl 1):35-8.

PMID:
2182976
[PubMed - indexed for MEDLINE]
8.

A randomized trial comparing hormone replacement therapy (HRT) and HRT plus calcitriol in the treatment of postmenopausal osteoporosis with vertebral fractures: benefit of the combination on total body and hip density.

Gutteridge DH, Holzherr ML, Retallack RW, Price RI, Will RK, Dhaliwal SS, Faulkner DL, Stewart GO, Stuckey BG, Prince RL, Criddle RA, Drury PJ, Tran L, Bhagat CI, Kent GN, Jamrozik K.

Calcif Tissue Int. 2003 Jul;73(1):33-43.

PMID:
14506952
[PubMed - indexed for MEDLINE]
9.

Long-term treatment with calcitriol in postmenopausal osteoporosis.

Caniggia A, Nuti R, Lore F, Martini G, Turchetti V, Righi G.

Metabolism. 1990 Apr;39(4 Suppl 1):43-9.

PMID:
2325571
[PubMed - indexed for MEDLINE]
10.

The effect of sodium monofluorophosphate plus calcium on vertebral fracture rate in postmenopausal women with moderate osteoporosis. A randomized, controlled trial.

Reginster JY, Meurmans L, Zegels B, Rovati LC, Minne HW, Giacovelli G, Taquet AN, Setnikar I, Collette J, Gosset C.

Ann Intern Med. 1998 Jul 1;129(1):1-8.

PMID:
9652994
[PubMed - indexed for MEDLINE]
11.

Treatment of postmenopausal osteoporosis with calcitriol or calcium.

Tilyard MW, Spears GF, Thomson J, Dovey S.

N Engl J Med. 1992 Feb 6;326(6):357-62.

PMID:
1729617
[PubMed - indexed for MEDLINE]
Free Article
12.

Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study.

Matsumoto T, Hagino H, Shiraki M, Fukunaga M, Nakano T, Takaoka K, Morii H, Ohashi Y, Nakamura T.

Osteoporos Int. 2009 Aug;20(8):1429-37. doi: 10.1007/s00198-008-0816-7. Epub 2008 Dec 20.

PMID:
19101754
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Effects of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis: a multi-center, randomized, placebo-controlled clinical trial.

Liu JL, Zhu HM, Huang QR, Zhang ZL, Li HL, Qin YJ, Zhang Y, Wei DL, Lu JH, Liu H, Chen XP, Liu YJ, Ekangaki A, Zheng YM, Diez-Perez A, Harper K.

Chin Med J (Engl). 2004 Jul;117(7):1029-35.

PMID:
15265377
[PubMed - indexed for MEDLINE]
14.

Clinical, biochemical and histological results of a double-blind trial with 1,25-dihydroxyvitamin D3, estradiol and placebo in post-menopausal osteoporosis.

Caniggia A, Delling G, Nuti R, Lorè F, Vattimo A.

Acta Vitaminol Enzymol. 1984;6(2):117-28.

PMID:
6388277
[PubMed - indexed for MEDLINE]
15.

Postmenopausal osteoporosis: no effect of three years treatment with 1,25-dihydroxycholecalciferol.

Falch JA, Odegaard OR, Finnanger AM, Matheson I.

Acta Med Scand. 1987;221(2):199-204.

PMID:
3035879
[PubMed - indexed for MEDLINE]
17.

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

Reginster J, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML, Lund B, Ethgen D, Pack S, Roumagnac I, Eastell R.

Osteoporos Int. 2000;11(1):83-91.

PMID:
10663363
[PubMed - indexed for MEDLINE]
18.
19.

Calcitriol. A review of its use in the treatment of postmenopausal osteoporosis and its potential in corticosteroid-induced osteoporosis.

Dechant KL, Goa KL.

Drugs Aging. 1994 Oct;5(4):300-17. Review.

PMID:
7827399
[PubMed - indexed for MEDLINE]
20.

Effectiveness and safety of vitamin D in relation to bone health.

Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.

PMID:
18088161
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk